Neola Medical EN
  • Lung Monitoring
  • The Technology
  • Our Studies
  • About Us
  • Career
  • Investors
    • To invest in Neola Medical
    • Risks and uncertainties
    • Stock information
    • Annual General Meeting (Swedish)
    • Corporate governance
    • Certified Adviser
    • Rights Issues (Swedish)
      • Riktad Emission 2023
      • Företrädesemission 2022
      • IPO 2020
        • Teckningsoptioner av serie TO1
    • Investor Relations
    • Investor letters
    • Presentations
    • Press Releases
    • Reports and Financial Calendar
  • News
    • Press Releases
    • Articles and posts
      • 2018 – 2024
      • 2025
Select Page
Neola Medical initiates market preparation work in the U.S. with an office in Palo Alto, Silicon Valley

Neola Medical initiates market preparation work in the U.S. with an office in Palo Alto, Silicon Valley

Jun 14, 2023

Press communication Lund, Sweden, June 14, 2023 This is a translation of the Swedish press release published 2023-06-14 Neola Medical AB (publ) announces today that the company, in addition to its headquarters in Lund, will increase the presence in the U.S. by an...
Neola Medical granted patent in the U.S. which open opportunities for lung monitoring of more patient groups

Neola Medical granted patent in the U.S. which open opportunities for lung monitoring of more patient groups

May 16, 2023

This is a translation of the Swedish press release published 2023-05-16 Neola Medical AB (publ) announces today that the company has been granted a new patent in the U.S. for an invention. This invention can enable measurement on more patient groups than preterm born...
Neola Medical’s CEO Hanna Sjöström presents at ABG Sundal Collier’s Life Science Summit Seminar on May 31

Neola Medical’s CEO Hanna Sjöström presents at ABG Sundal Collier’s Life Science Summit Seminar on May 31

May 15, 2023

This is a translation of the Swedish press release published 2023-05-15 Neola Medical AB (publ) will participate at ABG Sundal Collier’s Life Science Summit Seminar on May 31. CEO Hanna Sjöström will present the company at 13.00 and the presentation will be followed...
Neola Medical’s CEO tells more about the latest news in the new investor letter for spring 2023

Neola Medical’s CEO tells more about the latest news in the new investor letter for spring 2023

Apr 26, 2023

This is a translation of the Swedish press release published 2023-04-26 Approved grant from Vinnova for a collaborative project together with Lund University and Skåne University Hospital, attendance at Pediatric Academic Societies meeting 2023, the market...
Neola Medical will attend the Pediatric Academic Societies Meeting 2023 in Washington D.C. in the end of April where study results from the Irish research team will be presented

Neola Medical will attend the Pediatric Academic Societies Meeting 2023 in Washington D.C. in the end of April where study results from the Irish research team will be presented

Apr 18, 2023

This is a translation of the Swedish press release published 2023-04-18 Neola Medical AB (publ) will attend the Pediatric Academic Societies (PAS) Meeting 2023 in Washington D.C. in the end of April. The PAS meeting is an annual gathering for doctors, clinicians and...
Neola Medical will attend the Pediatric Academic Societies Meeting 2023 in Washington D.C. in the end of April where study results from the Irish research team will be presented

Vinnova grants Neola Medical, Skåne University Hospital and Lund University with a grant for a project that can enable lung monitoring of older children

Mar 30, 2023

This is a translation of the Swedish press release published 2023-03-30 Neola Medical AB (publ) announces today that the company together with Skåne University Hospital Lund and Lund University have received a grant from Medtech4Health and SWElife for a research...
« Older Entries
Next Entries »
About Neola Medical

Neola Medical AB (publ) aims to advance neonatal intensive care with Neola®, a medical device designed to enable continuous lung monitoring and real-time alerts of potentially life-threatening complications. The technology is based on a cutting-edge spectroscopic method that measures changes in lung volume and oxygen gas concentration. Neola® has the potential to support better care, shorten time spent in intensive care, and contribute to healthier lives for preterm born babies. Founded in 2016 and headquartered in Lund, Sweden, Neola Medical builds on Sweden’s legacy of medical technology innovation and contributions to global health care.

Sweden, HQ

Neola Medical AB
Ideon Gateway
Scheelevägen 27
223 63 Lund
info@neolamedical.com

U.S. Office

Neola Medical, Inc.
Nordic Innovation House
470 Ramona Street PMB
Palo Alto CA 94301-1707
info@neolamedical.com

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy